%0 Journal Article
%T Catecholaminergic Polymorphic Ventricular Tachycardia: A Review of Therapeutic Strategies.
%A Bergeman AT
%A Wilde AAM
%A van der Werf C
%J Card Electrophysiol Clin
%V 15
%N 3
%D 2023 09
%M 37558300
暂无%R 10.1016/j.ccep.2023.04.002
%X Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia syndrome characterized by bidirectional or polymorphic ventricular arrhythmia provoked by exercise or emotion. Most cases are caused by pathogenic variants in the gene encoding the cardiac ryanodine receptor (RYR2). The options for treating patients with CPVT have increased during the years, and evidence suggests that these have led to lower arrhythmic event rates. In addition, numerous potential new therapies are being investigated. In this review, we summarize the state of knowledge on both established and potential future treatment strategies for patients with CPVT and describe our approach to their management.